Examples of 'neuregulin' in a sentence
Meaning of "neuregulin"
neuregulin: A protein that acts as a signaling molecule in the nervous system, often studied in the context of neural development and function
Show more definitions
- Any of a family of proteins that have functions in the development of the nervous system.
How to use "neuregulin" in a sentence
Basic
Advanced
neuregulin
Use of a neuregulin to treat peripheral nerve injury.
These effects were observed following daily subcutaneous administration of neuregulin.
The neuregulin protein can be administered alone.
A standard curve is drawn by radioactivity versus unlabeled neuregulin amount.
Extended release of neuregulin for treating heart failure.
Neuregulin is predominantly expressed as a cell surface transmembrane protein.
Extended release of neuregulin for improved cardiac function.
Neuregulin antagonists and use thereof in treating cancer.
Certain disclosures are directed to neuregulin treatment of nerve injury following mastectomy.
Neuregulin based methods for treating heart failure.
Methods for measuring the concentration of neuregulin in the serum are known in the art.
Multiple neuregulin splice variants were cloned and produced.
The general pattern of three major transcripts has also been observed in the neuregulin gene.
Neuregulin protein encompasses neuregulin protein and peptide.
Relatively high conservation between neuregulin cytoplasmic tails from distant veterbrate species has been noted before.
See also
Neuregulin in the treatment of heart diseases.
Src is activated by the EGF receptor family ligand Neuregulin.
Therapeutic dosing of a neuregulin in the treatment or prophylaxis of heart failure.
Neukinase, a downstream protein of neuregulin.
A neuregulin for use in treating a cavernous nerve injury in a subject.
In certain embodiments, neuregulin is administered intravenously.
A neuregulin for use in preventing a cavernous nerve injury in a subject.
In certain embodiments, neuregulin is administered intramuscularly.
Neuregulin based methods and compositions for treating cardiovascular diseases.
In some embodiments, the neuregulin is administered by subcutaneous infusion.
Neuregulin nucleic acid encompasses neuregulin nucleic acid and neuregulin oligonucleotides.
In certain embodiments, neuregulin is administered subcutaneously.
Neuregulin nucleic acid encompasses neuregulin nucleic acid and neuregulin oligonucleotide.
In a eighth aspect, the use of neuregulin protein for preparation of a medication was provided.
Neuregulin treatment may or may not be contraindicated in patients with certain tumors.
In a tenth aspect, a method of treating chronic heart failure using neuregulin is provided.
In a further aspect a neuregulin can be any functional segment of a neuregulin polypeptide.
In certain embodiments the functional segment of a neuregulin contains an EGF-like domain.
Daily dosage of neuregulin in the therapeutic cycle is described in detail above.
Certain disclosures include the administration of neuregulin prior to and / or after surgery.
Daily dosage of neuregulin in the therapeutic cycle is described in detail below.
In another embodiment, using the compositions or formulations of neuregulin reduces side effects.
In a further aspect a neuregulin can be any functioval segment of a neuregulin polypeptide.
A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia.
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure.
Certain aspects include the administration of neuregulin prior to and / or after injury.
In certain disclosures neuregulin is used prophylactically thereby preventing or lessening a potential injury.
In this example, syringe pump is used for extended release of neuregulin in human patients.
In certain disclosures neuregulin is used prognostically to indicate the future status of the subject.
The present invention relates to neukinase, a downstream protein kinase in the neuregulin signaling pathway.
Extended release of neuregulin provides a continuous therapeutic level of neuregulin over a period of time.
The degree of receptor phosphorylation is then quantified by antiphosphotyrosine ELISA . Neuregulin.
Use of a neuregulin in the manufacture of a medicament for treating a cavernous nerve injury in a subject.
Certain aspects include wherein the neuregulin is administered prior to and / or after surgery.
Use of a neuregulin in the manufacture of a medicament for preventing a cavernous nerve injury in a subject.
